Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis

BioMed Research International - United States
doi 10.1155/2020/5353695
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Imaging for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Hepatology
MedicineHepatology
2017English

MicroRNA-21 as a Diagnostic Marker for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Pakistan Journal of Medical Sciences
Medicine
2019English

Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse

PLoS ONE
Multidisciplinary
2016English

Network Meta-Analysis of Treatments for Unresectable Hepatocellular Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

MicroRNA-122 Affects Cell Aggressiveness and Apoptosis by Targeting PKM2 in Human Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2015English

Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2018English

Prognostic Value of microRNAs in Hepatocellular Carcinoma: A Meta-Analysis

Oncotarget
Oncology
2017English

Analysis of Association Between Circulating miR-122 and Histopathological Features of Nonalcoholic Fatty Liver Disease in Patients Free of Hepatocellular Carcinoma

BMC Gastroenterology
MedicineGastroenterology
2016English

Meta-Analysis of DNA Methylation Biomarkers in Hepatocellular Carcinoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy